Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0398564 (
Adenylate kinase deficiency
)
3
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adenylate kinase deficiency
in the erythrocyte is a rare genetic disorder associated with hemolytic anemia. To determine the molecular basis of this disorder, we first cloned the normal gene encoding human cytosolic adenylate kinase (
AK1
) and determined the structure. The gene was 12 kilobase pairs long and was split into 7 exons. The structures of 5'- and 3'-flanking regions were determined by primer extension and RNA blot analysis. The results showed that two species of mRNA with 0.9 and 2.5 kilobases, which differed at the 3'-end portion, were generated by the
AK1
gene. Alu sequences were found in the largest intron (intron 5) and in the noncoding region of exon 7. Next, both alleles of the
AK1
gene were cloned from DNA of a patient bearing the adenylate kinase deficiency and their nucleotide sequences determined. A transition (C----T) was found in exon 6 on an allele, which resulted in an Arg to Trp (CGG----TGG) substitution at the 128th residue of
AK1
. Since chicken
AK1
is highly homologous to human
AK1
with respect to the amino acid sequence, we introduced an Arg to Trp substitution to chicken
AK1
at the same position by oligodeoxynucleotide-directed mutagenesis. The mutant chicken
AK1
expressed in Escherichia coli showed a reduced catalytic activity as well as a decreased solubility and a change in affinity to phosphocellulose. Thus it was considered that the observed C----T transition was a cause of the decreased
AK1
activity of the patient's erythrocyte. Analysis on phosphocellulose chromatography of erythrocyte
AK1
of the patient and parents revealed that the patient's mutant allele was derived from the mother.
...
PMID:Human adenylate kinase deficiency associated with hemolytic anemia. A single base substitution affecting solubility and catalytic activity of the cytosolic adenylate kinase. 254 24